Well-studied treatment for anemia due to CKD
EPOGEN (epogen.com) scores 74 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 37th percentile of 10846 Healthcare brands.
EPOGEN is a prescription medication used to treat anemia in patients with chronic kidney disease (CKD) who are on dialysis. It works by helping the body produce more red blood cells, which can reduce or eliminate the need for red blood cell transfusions. The drug has been used by more than 2.8 million people and is positioned as a well-studied treatment specifically for dialysis-related anemia. Its primary audience includes CKD dialysis patients, their caregivers, and healthcare providers.
| Brand Name | EPOGEN |
|---|---|
| Domain | epogen.com |
| Industry | Healthcare |
| Main Competitors | Aranesp (69/100), Procrit (61/100), Mircera (74/100), Retacrit (66/100) |
Moz Domain Authority 31/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "EPOGEN® is a prescription medication that is used to treat anemia for people with CKD on dialysis by helping the body create more red blood cells." (Meta description: 26 words (ideal length). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on X (Twitter), Instagram, GitHub; no detected presence on LinkedIn, Facebook, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
EPOGEN's main competitors in Healthcare: Aranesp (69/100), Procrit (61/100), Mircera (74/100), Retacrit (66/100).
Sources: Brand Analyzer scan
EPOGEN offers a single prescription medication designed to treat anemia caused by chronic kidney disease in patients undergoing dialysis, by stimulating red blood cell production.
Sources: EPOGEN official site
EPOGEN is a prescription pharmaceutical drug used to treat anemia in patients with chronic kidney disease who are on dialysis. It belongs to a class of medications that stimulate red blood cell production.
Sources: EPOGEN official site
EPOGEN has low AI-search visibility, scoring 23/100 on Brand Analyzer's AI visibility composite (visibility 17, trust 15, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: EPOGEN official site
EPOGEN helps the body produce more red blood cells in patients with chronic kidney disease on dialysis, addressing anemia caused by the disease and reducing or eliminating the need for red blood cell transfusions.
Sources: EPOGEN official site
EPOGEN scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: EPOGEN official site
EPOGEN is known for being a long-established, extensively studied treatment for anemia due to chronic kidney disease in dialysis patients, having been used by more than 2.8 million people.
Sources: EPOGEN official site
EPOGEN can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: EPOGEN official site
EPOGEN is used by patients with chronic kidney disease who are on dialysis and experiencing anemia. It is also relevant to their caregivers and healthcare providers who manage their treatment.
Sources: EPOGEN official site
EPOGEN scores 23/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
EPOGEN has a weak AI-visibility profile at 23/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is trust (15/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 31/100 and thin schema.org structured data.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to EPOGEN: e-pill (74/100), Envision (74/100), ERG (Eastern Research Group Inc.) (74/100), esanum (74/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.